Belatacept

This classification denotes an immunosuppressant with the molecular formula C3508H5440N922O1096S32, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E3B2GI648A, more generally known as belatacept. European Medicines Agency schedules belatacept in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20603. The term BELATACEPT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 1, 2008, list 59. BELATACEPT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule Belatacept under HS 30021095 and SITC 54163. SMILES:. As of Q4 2014, BELATACEPT remains US FDA's Preferred Term for this commodity. . Belatacept bears US NLM identifiers UMLS ID C1619962 and NCI Concept Code C80255.